Antiretroviral treatment in developing countries: the peril of neglecting private providers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12816829.
- Also identified by PMC identifier 1126254.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Increased access to antiretroviral drugs is vital to maintain developing countries with high rates of HIV infection. But unless treatment is properly controlled, these drugs could rapidly become useless
Medical subject headings
- Antiretroviral Therapy, Highly Active
- Developing Countries
- HIV Infections